| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,663 | 9,064 | 6,680 | 8,410 | | Cost of Revenue | 321 | 230 | 153 | 191 | | | Gross Profit | 8,342 | 8,834 | 6,526 | 8,219 | | | Operating Expenses | | Research Development | 11,106 | 11,972 | 12,323 | 13,847 | | Selling General and Administrative | 8,673 | 9,505 | 7,878 | 10,452 | | Non Recurring | (148) | 4,207 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (11,289) | (16,850) | (13,674) | (16,080) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 160 | 308 | 487 | 783 | | Earnings Before Interest And Taxes | (11,129) | (16,542) | (13,187) | (15,297) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (11,129) | (16,542) | (13,187) | (15,297) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,129) | (16,542) | (13,187) | (15,297) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,129) | (16,542) | (13,187) | (15,297) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,129) | ($16,542) | ($13,187) | ($15,297) |
|
0.02% Nasdaq 0.00%
Income Statement
